Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlie Gourley

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 26, 2021
DNA Methylation Profiles of Ovarian Clear Cell CarcinomaJulie M Cunningham, Stacey J Winham, Chen Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2024
Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian CancerRanjit Manchanda, Li Sun, Monika Sobocan, et al.
The Lancet. Oncology|July 28, 2022
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroupIgnace Vergote, Antonio Gonzalez-Martin, Domenica Lorusso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2022
Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and OutcomesKelly L Bolton, Denise Chen, Rosario Corona de la Fuente, et al.
Nature Genetics|August 15, 2018
Copy number signatures and mutational processes in ovarian carcinomaGeoff Macintyre, Teodora E Goranova, Dilrini De Silva, et al.
Nature Communications|July 2, 2025
Divergent trajectories to structural diversity impact patient survival in high grade serous ovarian cancerAilith Ewing, Alison Meynert, Ryan Silk, et al.
Gynecologic Oncology|January 7, 2020
Therapeutic options for mucinous ovarian carcinomaKylie L Gorringe, Dane Cheasley, Matthew J Wakefield, et al.
Cancer Research|May 20, 2016
The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and CisplatinYifan Wang, Andrea J Bernhardy, Cristina Cruz, et al.
Nature Reviews. Cancer|October 24, 2015
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerDavid D Bowtell, Steffen Böhm, Ahmed A Ahmed, et al.
BMJ Open|February 2, 2026
Protocol for the PROSECCA study: a new approach for predicting radiotherapy outcome using artificial intelligence and electronic population-based healthcare dataWilliam H Nailon, David J Noble, Ewen Harrison, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 26, 2021
DNA Methylation Profiles of Ovarian Clear Cell CarcinomaJulie M Cunningham, Stacey J Winham, Chen Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 12, 2024
Cost-Effectiveness of Unselected Multigene Germline and Somatic Genetic Testing for Epithelial Ovarian CancerRanjit Manchanda, Li Sun, Monika Sobocan, et al.
The Lancet. Oncology|July 28, 2022
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroupIgnace Vergote, Antonio Gonzalez-Martin, Domenica Lorusso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 11, 2022
Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and OutcomesKelly L Bolton, Denise Chen, Rosario Corona de la Fuente, et al.
Nature Genetics|August 15, 2018
Copy number signatures and mutational processes in ovarian carcinomaGeoff Macintyre, Teodora E Goranova, Dilrini De Silva, et al.
Nature Communications|July 2, 2025
Divergent trajectories to structural diversity impact patient survival in high grade serous ovarian cancerAilith Ewing, Alison Meynert, Ryan Silk, et al.
Gynecologic Oncology|January 7, 2020
Therapeutic options for mucinous ovarian carcinomaKylie L Gorringe, Dane Cheasley, Matthew J Wakefield, et al.
Cancer Research|May 20, 2016
The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and CisplatinYifan Wang, Andrea J Bernhardy, Cristina Cruz, et al.
Nature Reviews. Cancer|October 24, 2015
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerDavid D Bowtell, Steffen Böhm, Ahmed A Ahmed, et al.
BMJ Open|February 2, 2026
Protocol for the PROSECCA study: a new approach for predicting radiotherapy outcome using artificial intelligence and electronic population-based healthcare dataWilliam H Nailon, David J Noble, Ewen Harrison, et al.
Pageof 15